Sponsored Webinars
Using Stem Cells for Disease Modeling and Cell Therapy
Using Stem Cells for Disease Modeling and Cell Therapy
The Scientist Marketing Team |
Technical challenges in procuring, isolating, and deriving stem cells exist, as do the ethical controversies around the use of stem cells. This webinar brings together a panel of experts to discuss hope, the hype, and what we can realistically expect to see going forward.
Spotlight on Epigenetics Drug Discovery
Spotlight on Epigenetics Drug Discovery
The Scientist Marketing Team |
Efforts to unravel the epigenome and a deeper understanding of the role epigenetic pathways play in cell function and disease have led to intense drug-discovery initiatives both in academia and the pharma/biotech industry. The Scientist brings together a panel of experts to address some of the key questions that the field is grappling with today.
Mobile Applications Driving Data Efficiencies
Mobile Applications Driving Data Efficiencies
The Scientist Marketing Team |
In this webinar, The Scientist brings together technical experts to discuss mobile applications for data recording and analysis, data searches and journal access, real-time tracking of lab equipment, clinical data, patient information and other tasks that may seem too good to be true.
An Urgent Need for Validating and Characterizing Antibodies
An Urgent Need for Validating and Characterizing Antibodies
The Scientist Marketing Team |
Our panel of experts offer advice on what can be done to help solve common problems associated with antibody use, as well as, what should be done as a community to address this issue at large.
Tools and Strategies Driving Cancer Immunotherapy
Tools and Strategies Driving Cancer Immunotherapy
The Scientist Marketing Team |
The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy.
Use of Human Induced Pluripotent Stem Cells for Predicting Diverse Cardiotoxicities
Use of Human Induced Pluripotent Stem Cells for Predicting Diverse Cardiotoxicities
The Scientist Marketing Team |
The Scientist brings together a panel of experts to educate you about the successes and caveats of using iPSC-derived cells in toxicological assays.
Using Ingenuity Variant Analysis in Pharmacogenomics
Using Ingenuity Variant Analysis in Pharmacogenomics
The Scientist Staff |
This presentation covers sickle cell disease (SCD), specifically the genetic component to fetal hemoglobin response to hydroxyurea. Such knowledge will enhance the ability to predict drug response, improving patient care by allowing selection of individuals who will benefit most from hydroxyurea, and offer alternative therapies.
Use of Induced Pluripotent Stem Cells in Drug Discovery: Challenges and Opportunities
Use of Induced Pluripotent Stem Cells in Drug Discovery: Challenges and Opportunities
The Scientist Marketing Team |
The Scientist brings together a panel of experts who parse the hope and hype in an effort to educate the audience about the successes and caveats of using iPSCs.
Comprehensive Network and Pathway Analysis of RNA Sequencing Data from Triple Negative Breast Cancers
Comprehensive Network and Pathway Analysis of RNA Sequencing Data from Triple Negative Breast Cancers
The Scientist Marketing Team |
This webinar presents data on RNA-sequencing of triple-negative breast cancers (TNBCs) compared to microdissected normal breast tissues.
Innovative Cell Research
Innovative Cell Research
The Scientist Marketing Team |
To highlight some of the exciting areas where cells are pushing the boundaries in science, technology, and therapy, The Scientist has partnered with ATCC to launch a new webinar series on innovative cell research.